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Galactosyltransferase (EC 2.4.1.221, purified to homogeneity from human milk 
by affinity chromatography, had an apparent molecular weight of 53,000 as 
determined by denaturing polyacrylamide gel electrophoresis. Subtraction of 
the estimated contribution of the oligosaccharide portion of the molecule 
leaves a Mr of 47,000. An N-terminal amino acid sequence analysis of the 
isolated protein revealed a sequence similar to that found near the 5' end of 
a cDNA clone isolated by Shaper et al (111, which encodes a 35,500 molecular 
weight protein. Either the molecular weight of galactosyltransferase, has 
been overestimated, or a discrepancy exists between the actual molecular 
weight of galactosyltransferase and that predicted by the bovine cDNA clone 
isolated by Shaper et al (11). Q 1986 Academic FYSS. h. 
Lactose synthetase catalyzes the terminal step in the synthesis of lactose 
according to the reaction: 
UDP-galactose + glucose + lactose + UDP 
Enzymatic activity resulting in the synthesis of the galactose S1+4 glucose 
linkage in lactose was first demonstrated by Watkins and Hassid (13) in 
particulate fractions obtained from bovine and guinea pig lactating mammary 
glands. Lactose synthetase activity was later demonstrated in bovine milk by 
a number of subsequent investigators (1, 2, 3, 6, 10). Galactosyltransferase 
isolated from bovine milk whey by affinity chromatography demonstrates the 
presence of three species of enzyme having approximate molecular weights of 
54,000, 49,000 and 43,000 daltons (1). Gel filtration studies show that all 
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Biomedical Research Grants (NIH) 12 SO7 RR05700-15 and -16. 
Abbreviations: SDS-PAGE, polyacrylamide gel electrophoresis in the presence 
of sodium dodecylsulfate; IEF, isoelectric focusing; CNBr, cyanogen bromide. 
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three components are enzymatically active (10). Magee et al. (8) reported 
that the higher molecular weight form of the enzyme found in bovine milk 
could be converted to a lower molecular weight form by proteolysis. Gerber, 
Koxdrowski, Wyss and Berger (5) reported that galactosyltransferase, isolated 
from human milk, was homogeneous when analyzed by SDS-PAGE, but could be 
resolved into 13 different forms using isoelectric focusing. Since galacto- 
syltransferase is a glycosylated protein, the heterogeneity that Berger and 
associates observed could be a result of differences in glycosylation result- 
ing from post-translation processing of the enzyme. The low-degree of 
heterogeneity of the enzyme using SDS-PAGE suggested that the non-glycosyla- 
ted portion of the enzyme occuring in human milk could be homogeneous. The 
isolation of galactosyltransferase from human milk was therefore attempted in 
order to determine whether enough homogeneous enzyme could be obtained for 
amino acid sequencing. 
MATERIALS AND METHODS 
Galactosyltransferase Assay. Galactosyltransferase was measured by determin- 
ing the rate of transfer of [3H]-galactose from UDP-[3H]- alactose to the 
sugar acceptor, N-acetylglucosamine. The unreacted UDP-[ % HI-galactose was 
separated from the radioactive product of the reaction, f3H]-galactosyl-N- 
acetylglucosamine, by ion exchange chromatography as described by Barker et 
al. (1). 
Preparation of Affinity Columns. The hexanolamine derivative of N-acetylglu- 
cosamine was prepared as described by Barker et al (1) by condensing N- 
trifluoroacetyl-6-amino-1-hexanol with 3, 4, 6 tri-O-acetyl-2-acetamido-2- 
deoxy-B-D-glucopyranosyl chloride. The resultant compound, 6-amino-l-hexyl- 
2-acetamido-2-deoxy-B-D-glucopyranoside, was coupled to Sepharose 4B using 
CNBr. The ligand concentration was 1.2 mg of N-acetylglucosamine derivative 
per ml of wet Sepharose. Bovine a-lactalbumin was similarly coupled to 
Sepharose at a concentration of 3.5 mg per ml of Sepharose. 
Purification Procedure. One liter of pooled human milk was defatted by 
centrifugation at 17,000 x g for 20 minutes at 4°C. The defatted milk was 
brought to pH 4.6 by the addition of 4 M acetic acid, and dialyzed for 48 
hours against 2 changes of 20 liters of distilled water containing 10 ml of 
chloroform to prevent bacterial growth. After completion of the dialysis, 
the casein precipitate was removed by centrifugation at 17,000 x g for 20 
minutes at 4-C. The clear supernatant was brought to 25 mM in sodium cacody- 
late (pH 7.41, 25 r@l in MnC12 and 1 mM in 2-mercaptoethanol. The preparation 
was applied to a 500 ml (5 x 25 cm) N-acetylglucosamine-Sepharose column 
previously equilibrated with 25 mH sodium cacodylate, 25 mM MnC12, 1 mM 2- 
mercaptoethanol and 0.8 mM UMP. The column was washed with 6 bed volumes of 
the equilibration buffer. Elution was effected with 25 mM sodium cacodylate 
(pH 7.41, 8 mM N-acetylglucosamine, 1 mM 2-mercaptoethanol and 25 mM EDTA. 
'In order to restore the Mn++ concentration, the eluted enzyme was concen- 
trated to 3 ml using an Amicon PM 30 membrane, and then returned to a volume 
of 15 ml using a buffer solution containing 25 mM sodium cacodylate, (pH 
7.41, 25 ml-l MnC12, 1 mM P-mercaptethanol and 8 x&l N-acetylglucosamine. The 
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reconstituted enzyme solution was applied to a 1 x 19 cm o-lactalbumin- 
Sepharose column previously equilibrated with the same buffer as that used to 
reconstitute the enzyme preparation. The column was washed with 30 bed 
volumes of equilibration buffer, and the enzyme was eluted with equilibration 
buffer in which the N-acetylglucosamine was omitted. The eluted enzyme was 
collected in tubes containing a concentrated solution of N-acetylglucosamine 
which restored the concentration of that sugar to 8 mM. The elute was 
concentrated to 5 ml, applied to a second a-lactalbumin column, and affinity 
purified as just described. The enzyme that eluted from the second a-lact- 
albumin affinity column was concentrated to 1 ml and retained 90% of its 
activity for one month when stored at 4’C. 
Amino Acid Sequence Analysis. The purified protein was dialyzed against 5 mM 
ammonium bicarbonate and subsequently dried under vacuum. The preparation 
was then reduced under nitrogen in 0.2 M N-ethylmorpholinefacetate buffer, pH 
8.3, containing 6 M guanidine and 1 mM DTT and then alkylated with 4-vinyl- 
pyridine. Amino acid composition analysis and manual amino acid sequencing 
was then conducted as described by Tarr (12). 
Electrophoretic Analysis. Denatured proteins were separated by 10% SDS-PAGE 
77). After electrophoresis, proteins were stained with Coomassie brilliant 
blue and destained in 7.5% acetic acid. The two dimensional isoelectric 
focusing separation was performed as described by Kristjansson et al. (6). 
RESULTS AND DISCUSSION 
The yield of enzyme prepared by affinity chromatography ranged from 0.9 
to 1.3 mg per liter of milk in 4 consecutive runs. The preparation was homo- 
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Fig 2. Protein staining pattern of purified galactosyltransferase trans- 
ferass after two-dimensional LEF separation of proteins. A mixture of ampho- 
Lines (2.5% wt/vol; pH range 3.5-10.0) and sucrose (5% wt/vol final concen- 
tration) was added to the dialyzed, tyophiled samples. The samples were 
applied to a 5% polyasrylamide gel (0.15% bisacrylamide) containing ampho- 
lines (pli range 3.5-10.0; final concentration 2.5% wt/vol). A sample was 
applied to an IEF slab gel for separation in the first dimension. After 
running for 16 hours, a whole track was cut out and mounted on top of a SDS- 
PAGE slab gel for separation in the second dimension by size. After electro- 
phoresis, the proteins were stained with fast green. At the top, the pH in 
the LE:F gel is indicated as measured in a co-migrating track. The position 
of mol.ecular weight marker proteins are indicated. 
the purified galactosyltransferase was subjected to isoelectric focusing with 
a pH gradient of 3.5-10, it could be resolved into eight fractions (Fig. 2) 
which is a finding similar to that reported by Berger and associates (5). 
The estimated amino acid composition is shown in Table I. The total number 
of residues was estimated allowing for the carbohydrate composition of the 
glycoprotein which was assumed to be 10% by weight using a previous litera- 
ture report (4). The results of the N-terminal amino acid analysis are shown 
in Table II. The N-terminus of this preparation of galactosyltransferase was 
Fig. SDS-PAGE electrophoresis of purified galactosyltransfcrase. 
Protein samples were dialyzed, lyophilyzed and redissolved with heating 
(100°C for 5 minutes) in sample preparation buffer containing 2% 2-mercapto- 
ethanol. Electrophoresis on 10% polyacrylamide gels was performed at 25 
milliamps for 5 hours at room temperature. Proteins were stained with 
Coomassie brillant blue R. Three different concentrations of purified 
protein were applied to the gel. 
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TABLE I: Estimated number of 
residues per peptide from acid 
hydrolysis of galactosyltransferase 
TABLE 11: N-terminal amino acid 
sequence of human galactosyltransferase 
Ala 23.2 Leu 34.1 
Cya .o Met 8.5 
Asp 56.3 Pro 41.0 
Glu 34.0 Arg 31.1 
Phe 16.4 Ser 29.5 
Gly 40.1 Thr 16.0 
His 11.4 PeC 4.8 
Ile 18.4 Val 30.1 
Lys 9.2 Tyr 17.6 
THR GLY GLY ALA ARG PRO PRO PRO 
PRO LElJ GLY ALA SER SER GLN PRO 
not blocked since the amino acid sequence of that portion of the enzyme could 
be determined by sequential Edman degradations. The galactosyltransferase 
amino acid composition found in the current investigation showed fairly good 
correspondence to that of serum galactosyltransferase reported by Fujita- 
Yamaguchi and Yoshida (4). On the other hand, the amino acid composition of 
human milk galactosyltransferase had little resemblance to that reported by 
Podolsky and Weiser (9) for either of the enzymes that they designated as 
galactosyltransferase I and II. 
Shaper et al. (11) recently reported partial amino acid sequences for 
bovine galactosyltransferase, from which they constructed oligonucleotide 
probes for isolation of a cDNA clone specific for the bovine enzyme from a 
Xgtll bovine expression library. Our N-terminal sequence is partially homo- 
logous to a predicted sequence near the 5 ‘-end of their cDNA clone (i.e. near 
the N-terminus of the predicted amino acid sequence). Nine of the 16 amino 
acids in our N-terminal sequence agree in type and position with the predic- 
ted sequence near their N-terminus. However, the molecular weight that the 
nucleotide sequence of their cDNA clone predicts from this partially homolo- 
gous sequence to their translational stop codon is only about 35,500, whereas 
the apparent molecular weight of our purified enzyme containing this 
partially homologous N-terminal amino acid sequence is 53,000. When we 
subtract the estimated portion of the molecular weight contributed by the 
oligosaccharide component (-6,000) from 53,000, we are left with a molecular 
weight, due to the amino acids alone, of 47,000 rather than 35,500. We are 
currently attempting to resolve this discrepancy, 
228 















Barker, R., Olsen, K.W., Shaper, J.H. and Hill, R.L. (1972) J. Biol. 
Chem. 247, 7135-7147. 
Brew, K., Vanaman, T.C., Hill, R.L. (1968) Proc. Nat. Acad. Sci. 59, 
491-497. 
Brodbeck, U. and Ebner, K.E. (1966) J. Biol. Chem, 241, 762-764. 
Fujita-Yamaguchi, Y. and Yoshida, A. (1981) J. Biol. Chem. 256, 2701- 
2706. 
Gerber, AC, Kosdrowski, I, Wyss, S.R., Berger, E.G. (1979) Eur. J. 
Biochem. 93. 453-460. 
Kristjansson, G.I., Zwiers, H., Oestreicher, A.B., and Gispen, W.H. 
(1982) J. Neurochem. 39. 371-378. 
Laemmli, U.K., (1970) Nature 227, 680-685. 
Magee, S.C., Mawal, R. Rbner, K.E., (1973) J. Biol. Chem. 248, 7565- 
7569. 
Podolsky, D.K. and Weiser, M.M. (1979) J. Biol. Chem. 254, 3983- 
3990. 
Powell, J.T. and Brew, K. (1974) Eur. J. Biochem. 48, 217-228. 
Shaper, N.L., Shaper, J.H., Neuth, J.L., Fox, J.L., Chang, H., Kirsch, 
I.R., Hollis, G.F. (1986) Proc. Natl. Acad. Sci. 83, 1573-77. 
Tarr, G.E. (1986) Microcharacterization of Polypeptides, pp. 155-194, 
Humana Press Inc., Clifton, NJ. 
Watkins, W.M. and Hassid, W.Z. (1962) J. Biol. Chem. 237, 1432-1440. 
229 
